Navigation Links
Cornerstone Therapeutics Reports First Quarter 2009 Financial Results
Date:5/7/2009

2008, an increase of approximately $2.3 million, or 147%. This increase was primarily due to a $1.0 million increase related to public company legal and accounting costs and a $0.6 million increase in employee and travel expenses resulting from our growth.

Research and development expenses were $1.2 million in the 2009 first quarter, compared to $98,000 in the 2008 first quarter, an increase of approximately $1.1 million, or 1086%. Research and development expenses in the most recent first quarter included additional expenses related to on-going pipeline development.

For the three months ended March 31, 2009, the Company had operating income of $10.4 million, or 33.9% of net revenues, compared with operating income of $1.4 million, or 14.9% of net revenues, for the same period in 2008, an increase of approximately 658%. The Company's first quarter 2009 net income and diluted earnings per share were $6.3 million and $0.48, respectively.

"We are extremely pleased with our financial performance in the first quarter, as we delivered substantial growth in operating income, and further strengthened our balance sheet," said Craig A. Collard, Cornerstone's President and Chief Executive Officer. "Also, our sales and marketing strategies for key products, including SPECTRACEF, ZYFLO CR and ALLERX, continued to gain traction with net product sales more than tripling year-over-year. In addition, our existing product pipeline continues to move forward."

As of March 31, 2009, the Company had $10.7 million in cash and cash equivalents, an increase of $1.5 million compared to December 31, 2008.

2009 Outlook

Following this strong start to the year, the Company is raising its full year guidance for net revenues from over $80 million to over $95 million. In addition, the Company is increasing its income from operations estimate from in excess of $10 million to in excess
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
2. Cornerstone Therapeutics to Host First Quarter 2009 Conference Call
3. OnCore(r) 9.0 Released: 'Top 5' Priorities and Collaborative Initiatives Cornerstones of Product Development
4. Cornerstone Therapeutics Announces New Board of Directors
5. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
6. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
7. Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25
8. Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009
9. Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
10. Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections
11. Prime Therapeutics Announces Departure of President and Chief Executive Officer Timothy Dickman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... in Charlottesville, VA. McCartney is one of the most ... this beloved performer continues to roll along with no signs ... legendary groups: Wings and The Beatles, has been celebrating his ... the “Out There” tour and has continually added new stops ...
(Date:5/4/2015)... New findings released today from a poll conducted ... people diagnosed with a brain tumor needed more information ... at the time of diagnosis, and had only a ... course of treatment. The release of these findings corresponds ... volunteer network, the ABTA CommYOUnity™, dedicated to serving the ...
(Date:5/4/2015)... Fork, UT (PRWEB) May 04, 2015 ... surgery (up to $3,000) of one patient receiving care at ... of Utah. The procedure must be performed by July ... (willing to pay in full up front and forego the ... U.S. becomes more economically burdensome every year, and it devastates ...
(Date:5/4/2015)... Sheltering Arms announced that it has ... The Mother Hale Learning Center meets a tremendous need ... Sheltering Arms will begin operating the site immediately and ... the center. , Opened in 2006, the Mother Hale ... five years, many of whom come from high-need backgrounds. ...
(Date:5/4/2015)... Helena, MT (PRWEB) May 04, 2015 ... partnered with Care to Care, LLC to manage outpatient ... will help New West Medicare ensure its members are ... avoid unnecessary radiation. , Working closely with New West ... in promoting the safe use of advanced imaging and ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2
... Mainstream Management ProcessSTUART, Fla., March 20 /PRNewswire/ ... community-based healthcare organization covering two counties in Florida, ... interests for its board of directors, committee members ... a moderately sized community, it was not uncommon ...
... the Migraine Research Foundation (MRF) announced a new initiative ... migraine called FOR OUR CHILDREN. The new program ... understanding of migraine and its causes and treatments in ... , Migraine is very common in children - ...
... and You Could Also Win a $25 Visa(R) Gift Card ... much calcium you need each day? Or which foods are ... answers to these and other nutrition questions, then pull up ... Take the Shedd,s Spread Country Crock (R) Calcium quiz ...
... Corporation (NYSE: HLS ) announced today that ... dividend of $16.25 per share on its 6.5% Series ... 2009, to holders of record on April 1, 2009. ... largest provider of inpatient rehabilitative healthcare services. Operating in ...
... techniques, the accuracy of preoperative rectal cancer staging has ... rectal cancer patients has become a very important aim ... published on March 14, 2009 in the World ... 5-year survival after local excision of rectal cancer, and ...
... University, together with colleagues at the Karolinska Institute and ... the determine the dosage of the blood-thinning drug warfarin. ... PLoS Genetics . , "We have previously studied selected ... have gone in and scanned the entire genome, we ...
Cached Medicine News:Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 2Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 3Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 4Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 5Health News:New initiative to support pediatric migraine research is announced 2Health News:Bone Up On Calcium and Vitamin D for a Chance to Win a Family Vacation to Yellowstone National Park 2Health News:Bone Up On Calcium and Vitamin D for a Chance to Win a Family Vacation to Yellowstone National Park 3
(Date:5/4/2015)... TAIPEI , May 4, 2015 ... partner, Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... BAX ) jointly announced that Baxter has ... European Medicines Agency (EMA) for MM-398 (irinotecan liposome ... metastatic adenocarcinoma of the pancreas who have been ...
(Date:5/4/2015)... DOYLESTOWN, Pa. , May 4, 2015  Makindus, ... announced today that the European Medicines Agency (EMA) has ... for the treatment of Stargardt,s Disease. "We ... for MI-100 to treat Stargardt,s disease in place for ... our development program in the United States ...
(Date:5/4/2015)... Bayer HealthCare (Bayer) has entered into an ... ISIS ) on ISIS-FXI Rx, an antisense investigational ... Under the agreement Bayer will further develop and commercialize ... need. As part of the clinical development program, Bayer ... in an appropriate patient community. "Bayer ...
Breaking Medicine Technology:PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3
... Delcath Systems, Inc. (Nasdaq: DCTH ) announced ... discuss its recent corporate developments and update its progress on ... President and Chief Executive Officer will host the call. ... 800-322-5044 for domestic participants and 617-614-4927 for international participants, both ...
... 2011 CVS Caremark Corporation (NYSE: CVS ... present at two investor conferences in the month of ... CVS Caremark, will be making a presentation to investors ... on Thursday, November 10th, at approximately 10:00 a.m. MST ...
Cached Medicine Technology:Delcath Systems to Report Third Quarter Progress and Conduct Conference Call 2Delcath Systems to Report Third Quarter Progress and Conduct Conference Call 3CVS Caremark to Present at Upcoming Conferences 2
... proven electrophoretic transfer apparatus incorporating state-of-the-art plate ... Its design allows for a very close ... with a low voltage power source such ... field in volts/cm. The result is exceptionally ...
... RNA from agarose gels to hybridization membranes ... speed and efficiency of transfer by allowing ... ,Part of an integrated system allowing electrophoresis, ... 2.5 hours, versus 29 hours required for ...
... Transfers depurinated DNA and RNA from agarose ... as 15 minutes ,Increases speed and efficiency ... be applied to gel ,Part of an ... and UV crosslinking in 2.5 hours, versus ...
Ice block will provide sufficient cooling for most normal blotting applications. Sealed block is held submerged in transfer buffer. Ice block will not spill during refreezing....
Medicine Products: